To estimate the prevalence and trend of obesity in primary school-age children, obesity survey was performend in children aged 6 to 12 years(5,226 boys and 5,048 girls)in Kwangju in 1991. Obesity was defined as overweight if more than 20 per cent above the median weight for height and age(relative weight>120%). The following results were obtained: 1) The prevalence of obesity that exceeded the weight centiles at each height by more than 97th percentile was 8.78. Boys (9.70%)was not significantly higher than in girls(7.82%)(p>0.05). 2) The prevalence of obesity that exceeded the standard weight for height by more than 20% was 8.82%. Among them, 5.45% were mild obesity and 2.93% were moderate obesity and 0.44% were severe obesity. The prevalence rate of obesity was no significant differences by sex(p>0.05). 3) Regionally, the prevalence of obesity was a lower rate in Kwangiu in 1991 (8.82%)than that in Seoul in 1989(11.68%).
Child* ; Gwangju* ; Humans ; Obesity* ; Obesity, Morbid ; Overweight ; Prevalence* ; Seoul

No abstract available.
Immunoglobulins* ; Metabolism* ; Nephrotic Syndrome*

No abstract available.
Adrenalectomy* ; Multiple Endocrine Neoplasia* ; Pheochromocytoma*

No abstract available.
Stomach Neoplasms*

No abstract available.
Stomach Neoplasms*

PURPOSE: Palmitic acid in infant formulas has been shown to lower calcium and fat absorption because of its structural difference from human milk. Some studies reported the inclusion of palm and palm olein oil in infant formula led to lower bone mineralization. We aimed to determine whether the sn-2 position palmitic acid fortified infant formula influences growth and skeletal development, by comparing bone mineral accretion and bone markers in formula-fed infants to those in breast-fed ones. METHODS: We determined anthropometrics and feeding intake in three groups of full term newborn infants fed different diets at 6 and 12 weeks after birth; Group A (n=15) was fed human milk, Group B (n=15) was fed formula alpha (31% sn-2 palmitic acid as a mainly plant source), Group C (n=15) was fed formula beta (31% sn-2 palmitic acid as a mainly animal source). Total body bone mineral content (BMC) and bone mineral density (BMD) were measured at 12 weeks of age using dual energy X-ray absorptiometry. We measured bone-specific alkaline phosphatase (B-ALP), C-terminal propeptide of type 1 collagen (CICP) as markers for bone formation, and deoxypyridinoline crosslinks (total DPD) as a marker for bone resorption at 6 and 12 weeks. RESULTS: There were no significant differences between feeding groups in body weight, height, head circumference, and skinfold thickness at 6 and 12 weeks. The concentrations of B-ALP, CICP, and total DPD were not significantly different between feeding groups at 6 weeks. The concentrations of B-ALP and total DPD were not significantly different between feeding groups at 12 weeks. The concentrations of CICP in Group B and C were higher than that of Group A (P<0.05). BMC and BMD in formula-fed infants (Group B and C) were not different from those of breast-fed ones (Group A). BMC and BMD in Group B were higher than that of Group C (P<0.05). CONCLUSION: The growth and bone mineralization in infants fed sn-2 position palmitic acid fortified formula were not different in those of breast-fed ones.
Absorptiometry, Photon ; Absorption ; Alkaline Phosphatase ; Animals ; Body Weight ; Bone Density ; Bone Resorption ; Calcification, Physiologic ; Calcium ; Collagen Type I ; Diet ; Head ; Humans ; Infant Formula ; Infant* ; Infant, Newborn ; Metabolism* ; Milk, Human ; Osteogenesis ; Palmitic Acid* ; Parturition ; Plants ; Skinfold Thickness

No abstract available.
Recurrence* ; Urinary Bladder Neoplasms* ; Urinary Bladder*

We report a 37 year-old-female patient with papillary thyroid cancer treated by surgery who demonstrated residual thyroid and bilateral breast uptake on a diagnostic I-131 whole body scan. She had an extrathyroidal extension needing I-131 ablative therapy. Her galactorrhea was investigated and treated with low doses of bromocriptine prior to I-131 therapy. Her galactorrhea was due to the decreased secretion of PIF induced by empty sella.
Breast* ; Bromocriptine ; Empty Sella Syndrome* ; Female ; Galactorrhea ; Humans ; Hyperprolactinemia* ; Pregnancy ; Thyroid Gland* ; Thyroid Neoplasms* ; Whole Body Imaging

No abstract available.
Enterotoxigenic Escherichia coli* ; Enterotoxins*

No abstract available.
Anemia, Hemolytic, Autoimmune* ; Child* ; Hepatitis, Chronic* ; Humans